MedPath

THE UNIVERSITY OF HONG KONG

🇭🇰Hong Kong, China
Ownership
-
Employees
-
Market Cap
-
Website

Optimizing HBV Management During Anti-CD20 Antibodies

Completed
Conditions
Liver Dysfunction
Immune Suppression
Hepatitis B
Interventions
Drug: Anti-CD20 antibody
First Posted Date
2017-05-16
Last Posted Date
2018-05-04
Lead Sponsor
The University of Hong Kong
Target Recruit Count
83
Registration Number
NCT03155984
Locations
🇭🇰

The University of Hong Kong, Hong Kong, Hong Kong

Study of Xeloxiri Regimen for Patients With Refractory Metastatic Colorectal Cancer

Phase 2
Completed
Conditions
Colorectal Cancer
Interventions
First Posted Date
2017-05-09
Last Posted Date
2017-05-09
Lead Sponsor
The University of Hong Kong
Target Recruit Count
32
Registration Number
NCT03146377
Locations
🇭🇰

Queen Mary Hospital, The University of Hong Kong, Hong Kong, Hong Kong

Training Program for Community Health Campaign: Fitter Families Project

Not Applicable
Completed
Conditions
Motor Activity
Interventions
Behavioral: Training group
First Posted Date
2017-05-09
Last Posted Date
2018-05-14
Lead Sponsor
The University of Hong Kong
Target Recruit Count
28
Registration Number
NCT03146169
Locations
🇭🇰

Christian Family Service Centre, Kwun Tong, Hong Kong

Smoking Cessation Programme in Workplaces in Hong Kong (Phase III)

Not Applicable
Completed
Conditions
Smoking Cessation
Interventions
Behavioral: Health talk plus intensive social media intervention
Behavioral: Health talk plus less intensive social media intervention
First Posted Date
2017-05-05
Last Posted Date
2021-09-21
Lead Sponsor
The University of Hong Kong
Target Recruit Count
679
Registration Number
NCT03142555
Locations
🇭🇰

School of Nursing, The University of Hong Kong, Hong Kong, Hong Kong

Combination of Quizartinib and Omacetaxine Mepesuccinate for AML Carrying FLT3-ITD

Phase 2
Conditions
FLT3-ITD Mutation
AML
Interventions
Drug: Quizartinib
Drug: Omacetaxine Mepesuccinate Injection
First Posted Date
2017-05-01
Last Posted Date
2020-12-10
Lead Sponsor
The University of Hong Kong
Target Recruit Count
40
Registration Number
NCT03135054
Locations
🇭🇰

The University of Hong Kong, Hong Kong, Hong Kong

Cessation of Tyrosine Kinase Inhibitors in Patients With Chronic-phase Chronic Myelogenous Leukaemia

Conditions
Leukemia, Myelogenous, Chronic Phase
First Posted Date
2017-04-27
Last Posted Date
2018-06-11
Lead Sponsor
The University of Hong Kong
Target Recruit Count
30
Registration Number
NCT03131986
Locations
🇭🇰

The University of Hong Kong, Hong Kong, Hong Kong

Sinew Acupuncture for Knee Osteoarthritis

Not Applicable
Completed
Conditions
Knee Osteoarthritis
Interventions
Other: Sinew acupuncture
Other: Sham acupuncture
First Posted Date
2017-04-04
Last Posted Date
2018-12-13
Lead Sponsor
The University of Hong Kong
Target Recruit Count
86
Registration Number
NCT03099317
Locations
🇭🇰

The Hong Kong Tuberculosis, Association The University of Hong Kong Clinical Centre for Teaching and Research in Chinese Medicine (Wan Chai), Wan Chai, Hong Kong

MRI Differentiating Gut TB and Crohn's

Completed
Conditions
Crohn Disease
Intestinal Tuberculosis
Interventions
Diagnostic Test: Magnetic resonance imaging
First Posted Date
2017-03-30
Last Posted Date
2019-04-17
Lead Sponsor
The University of Hong Kong
Target Recruit Count
120
Registration Number
NCT03096379
Locations
🇨🇳

The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong, China

Circulating Tumor DNA (ctDNA) as a Prognostic Tool in Patients With Advanced Lung Adenocarcinoma

Conditions
Adenocarcinoma of Lung (Disorder)
Interventions
Genetic: Sequencing of ctDNA in plasma
First Posted Date
2017-03-27
Last Posted Date
2017-03-27
Lead Sponsor
The University of Hong Kong
Target Recruit Count
100
Registration Number
NCT03090815
Locations
🇭🇰

University of Hong Kong Queen Mary Hospital, Hong Kong, Hong Kong

The Use of Decitabine as Induction Therapy for Acute Myeloid Leukemia With Complex and/or Monosomal Karyotype

Phase 2
Conditions
Acute Myeloid Leukemia
Complex Karyotype
Interventions
First Posted Date
2017-03-15
Last Posted Date
2021-04-28
Lead Sponsor
The University of Hong Kong
Target Recruit Count
20
Registration Number
NCT03080766
Locations
🇭🇰

The University of Hong Kong, Hong Kong, Hong Kong

© Copyright 2025. All Rights Reserved by MedPath